<DOC>
	<DOCNO>NCT02952196</DOCNO>
	<brief_summary>Addiction amphetamine characterize alternate phase intoxication short abstinence , follow recurrent drug-craving episode result distress relapse . Addiction involve number neurotransmission system , include endocannabinoid system ( ECBS ) . Cannabidiol ( CBD ) , second abundant component cannabis , know broad spectrum physiological , anxiolytic neuroprotective property . It show multiple therapeutic property treat anxiety , schizophrenia interestingly CBD show potentially helpful treat addiction , due effect various neuronal circuit involve disorder . The investigator overall hypothesis CBD interesting pharmacological contender decrease amphetamine crave treat amphetamine addiction .</brief_summary>
	<brief_title>Cannabidiol New Intervention Amphetamine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Dextroamphetamine</mesh_term>
	<criteria>Current DSMV criterion amphetamine use disorder Current amphetamine use last use two week prior admission study Subject treatment amphetamine dependence time study Ability give valid , informed consent Severe and/or unstable hepatic , neurologic ( include diagnosis seizure ) , cardiac ( include arrhythmia ) renal disease , severe unstable medical condition precludes safe participation study accord study physician . Hypersensitivity cannabinoids excipients investigational medicinal product . Severe psychiatric condition ( history schizophrenia , schizoaffective disorder bipolar disorder ; current acute psychosis , mania severe suicidality Inability ( unwillingness ) woman childbearing potential use medically acceptable form contraception throughout study duration 3 month dose stop . Couples plan conceive within next 12 month . Men history treatment fertility problem . Another current severe substance use disorder substance use disorder would require pharmacological treatment study accord addiction specialist except nicotine ( e.g . benzodiazepine opiate alcohol opioid use disorder ) Current regular treatment psychotropic medication ( benzodiazepine anticonvulsant ) , opioid medication ( include methadone suboxone ) anticipation patient may need initiate treatment study . Any serious medical condition psychiatric illness precludes subject signing informed consent form To assess whether subject normal eligible participate , ask fill preMRI safety screen form radiologist 's team ass his/her eligibility .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Amphetamine</keyword>
	<keyword>Stress</keyword>
	<keyword>Craving</keyword>
	<keyword>CBD</keyword>
</DOC>